BFEC
IMMU

Benjamin F. Edwards & Company’s Immunomedics Inc IMMU Stock Holding History

Benjamin F. Edwards & Company’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-664
Closed -$10K – 1678
2018
Q1 		$10K Hold
664
– – ﹤0.01% 1274
2017
Q4 		$11K Buy
+664
New +$7.84K ﹤0.01% 1188

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Benjamin F. Edwards & Company's IMMU Position: Q2 2018 in Review

Benjamin F. Edwards & Company sold out of Immunomedics Inc (IMMU) in Q2 2018, closing a stake of 664 shares — an estimated $10K sold.

Benjamin F. Edwards & Company first reported a position in IMMU in Q4 2017 and held it in 2 quarters. The position peaked at $11K in Q4 2017. 192 funds tracked by Wall St. Rank hold IMMU as of Q2 2018.

  • Benjamin F. Edwards & Company reported no remaining Immunomedics Inc position as of Q2 2018 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 664 Immunomedics Inc shares in Q2 2018, an estimated $10K.
  • Benjamin F. Edwards & Company first reported a position in Immunomedics Inc in Q4 2017 and held it in 2 quarters.
  • Benjamin F. Edwards & Company's Immunomedics Inc position peaked at $11K in Q4 2017.
  • 192 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2018.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2018, filed 19 Jul 2018.